Hsbc Holdings PLC Cassava Sciences Inc Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 14,762 shares of SAVA stock, worth $24,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,762Holding current value
$24,357% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
190Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$5.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$4.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$1.66 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$1.64 Million0.0% of portfolio
-
Ubs Group Ag931KShares$1.54 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $66.2M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...